MR-Guided Cryoablation of Prostate Bed Recurrences

Technical Success, Safety, and Short and Long-term Efficacy for MR-Guided Cryoablation of Prostate Bed Recurrences

Status

Active, not recruiting

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01727284

Enrollment

107

Registered

2012-11-15

Start date

2012-12-12

Completion date

2026-11-30

Last updated

2025-09-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate Tumors

Brief summary

The purpose of this research is to see if MR-guided cryoablation can effectively treat prostate tumor recurrences.

Interventions

PROCEDUREMR-guided cryoablation

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

MALE

Age

30 Years to 100 Years

Healthy volunteers

Inclusion criteria

* Patients with biopsy proven soft tissue tumor recurrences of prostate fossa * Surgery is not a desirable alternative therapy at the time of enrollment * Radiation therapy has failed or not indicated or can be safely postponed * Tumor size is \< 5 cm at its largest diameter * Tumor does not encompass the rectal wall or external urethral sphincter * Patient is able to undergo MRI

Exclusion criteria

* N/A

Design outcomes

Primary

Measure	Time frame
Evaluation of target lesion at 3-6, 12, 24, and 36 month imaging follow-up	3 years

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026